Sung H , Ferlay J , Siegel RL , Laversanne M , Soerjomataram I , Jemal A , et al . Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin . 2021 ; 71 ( 3 ): 209 – 49 .

Boilly B , Faulkner S , Jobling P , Hondermarck H . Nerve dependence: from regeneration to cancer . Cancer Cell . 2017 ; 31 ( 3 ): 342 – 54 .

Johnston APW , Miller FD . The contribution of innervation to tis‑sue repair and regeneration . Cold Spring Harb Perspect Biol . 2022 ; 14 ( 9 ): a041233 .

Magnon C , Hondermarck H . The neural addiction of cancer . Nat Rev Cancer . 2023 ; 23 ( 5 ): 317 – 34 .

Winkler F , Venkatesh HS , Amit M , Batchelor T , Demir IE , Deneen B , et al . Cancer neuroscience: state of the field, emerging directions . Cell . 2023 ; 186 ( 8 ): 1689 – 707 .

Monje M , Borniger JC , D’Silva NJ , Deneen B , Dirks PB , Fattahi F , et al . Roadmap for the emerging field of cancer neuroscience . Cell . 2020 ; 181 ( 2 ): 219 – 22 .

Griffin N , Faulkner S , Jobling P , Hondermarck H . Targeting neurotrophin signaling in cancer: the renaissance . Pharmacol Res . 2018 ; 135 : 12 – 7 .

Bahmad HF , Wegner C , Nuraj J , Avellan R , Gonzalez J , Mendez T , et al . Perineural invasion in breast cancer: a comprehensive review . Cancers (Basel) . 2025 ; 17 ( 12 ): 1900 .

Gysler SM , Drapkin R . Tumor innervation: peripheral nerves take control of the tumor microenvironment . J Clin Invest . 2021 ; 131 ( 11 ): e147276 .

Zahalka AH , Frenette PS . Nerves in cancer . Nat Rev Cancer . 2020 ; 20 ( 3 ): 143 – 57 .

Chen H , Liu D , Guo L , Cheng X , Guo N , Shi M . Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre‑metastatic niche through activating β‑adrenergic signaling . J Pathol . 2018 ; 244 ( 1 ): 49 – 60 .

Ceyhan GO , Bergmann F , Kadihasanoglu M , Erkan M , Park W , Hinz U , et al . The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis . Gut . 2007 ; 56 ( 4 ): 534 – 44 .

Flores ER , Sawyer WG . Engineering cancer’s end: an interdiscipli‑nary approach to confront the complexities of cancer . Cancer Cell . 2024 ; 42 ( 7 ): 1133 – 7 .

Hernandez S , Serrano AG , Solis Soto LM . The role of nerve fibers in the tumor immune microenvironment of solid tumors . Adv Biol . 2022 ; 6 ( 9 ): e2200046 .

Knox SM , Lombaert IM , Reed X , Vitale‑Cross L , Gutkind JS , Hoffman MP . Parasympathetic innervation maintains epithelial progenitor cells dur‑ing salivary organogenesis . Science . 2010 ; 329 ( 5999 ): 1645 – 7 .

Knox SM , Lombaert IM , Haddox CL , Abrams SR , Cotrim A , Wilson AJ , et al . Parasympathetic stimulation improves epithelial organ regenera‑tion . Nat Commun . 2013 ; 4 : 1494 .

Carmeliet P . Angiogenesis in health and disease . Nat Med . 2003 ; 9 ( 6 ): 653 – 60 .

Saloman JL , Albers KM , Li D , Hartman DJ , Crawford HC , Muha EA , et al . Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer . Proc Natl Acad Sci U S A . 2016 ; 113 ( 11 ): 3078 – 83 .

Silva D , Quintas C , Gonçalves J , Fresco P . Contribution of adrenergic mechanisms for the stress‑induced breast cancer carcinogenesis . J Cell Physiol . 2022 ; 237 ( 4 ): 2107 – 27 .

Albo D , Akay CL , Marshall CL , Wilks JA , Verstovsek G , Liu H , et al . Neuro‑genesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes . Cancer . 2011 ; 117 ( 21 ): 4834 – 45 .

Allen JK , Armaiz‑Pena GN , Nagaraja AS , Sadaoui NC , Ortiz T , Dood R , et al . Sustained adrenergic signaling promotes intratumoral innervation through bdnf induction . Cancer Res . 2018 ; 78 ( 12 ): 3233 – 42 .

Partecke LI , Speerforck S , Käding A , Seubert F , Kühn S , Lorenz E , et al . Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta‑adrenergic receptor blockade . Pancreatology . 2016 ; 16 ( 3 ): 423 – 33 .

Schonkeren SL , Thijssen MS , Vaes N , Boesmans W , Melotte V . The emerging role of nerves and glia in colorectal cancer . Cancers (Basel) . 2021 ; 13 ( 1 ): 152 .

Le TT , Oudin MJ . Understanding and modeling nerve‑cancer interac‑tions . Dis Model Mech . 2023 ; 16 ( 1 ): dmm049729 .

Jurcak NR , Rucki AA , Muth S , Thompson E , Sharma R , Ding D , et al . Axon guidance molecules promote perineural invasion and metas‑tasis of orthotopic pancreatic tumors in mice . Gastroenterology . 2019 ; 157 ( 3 ): 838 – 50.e6 .

Jiang CC , Marsland M , Wang Y , Dowdell A , Eden E , Gao F , et al . Tumor innervation is triggered by endoplasmic reticulum stress . Oncogene . 2022 ; 41 ( 4 ): 586 – 99 .

Banh RS , Biancur DE , Yamamoto K , Sohn ASW , Walters B , Kuljanin M , et al . Neurons release serine to support mrna translation in pancreatic cancer . Cell . 2020 ; 183 ( 5 ): 1202 – 18.e25 .

Jiang S‑H , Zhang S , Cai Z , Yu M‑H , Li H , Jiang L , et al . Mechanical cues of extracellular matrix determine tumor innervation . bioRxiv . 2024 : 2024.03.25.586535 .

Madeo M , Colbert PL , Vermeer DW , Lucido CT , Cain JT , Vichaya EG , et al . Cancer exosomes induce tumor innervation . Nat Commun . 2018 ; 9 ( 1 ): 4284 .

Vermeer PD . Exosomal induction of tumor innervation . Cancer Res . 2019 ; 79 ( 14 ): 3529 – 35 .

Hoffman MT , Kemp SB , Salas‑Escabillas DJ , Zhang Y , Steele NG , The S , et al . The gustatory sensory g‑protein gnat3 suppresses pancre‑atic cancer progression in mice . Cell Mol Gastroenterol Hepatol . 2021 ; 11 ( 2 ): 349 – 69 .

Ge Y , Liu H , Zhang Y , Liu J , Yan R , Xiao Z , et al . Inhibition of DCLK1 kinase reverses epithelial‑mesenchymal transition and restores T‑cell activity in pancreatic ductal adenocarcinoma . Transl Oncol . 2022 ; 17 : 101317 .

Ma Z , Lytle NK , Chen B , Jyotsana N , Novak SW , Cho CJ , et al . Single‑cell transcriptomics reveals a conserved metaplasia program in pancreatic injury . Gastroenterology . 2022 ; 162 ( 2 ): 604 – 20.e20 .

DelGiorno KE , Chung CY , Vavinskaya V , Maurer HC , Novak SW , Lytle NK , et al . Tuft cells inhibit pancreatic tumorigenesis in mice by producing prostaglandin d 2 . Gastroenterology . 2020 ; 159 ( 5 ): 1866 – 81.e8 .

Salas‑Escabillas DJ , Hoffman MT , Brender SM , Moore JS , Wen HJ , Benitz S , et al . Tuft cells transdifferentiate to neural‑like progenitor cells in the progression of pancreatic cancer . Dev Cell . 2025 ; 60 ( 6 ): 837 – 52.e3 .

Amit M , Takahashi H , Dragomir MP , Lindemann A , Gleber‑Netto FO , Pickering CR , et al . Loss of p53 drives neuron reprogramming in head and neck cancer . Nature . 2020 ; 578 ( 7795 ): 449 – 54 .

Ayanlaja AA , Ji G , Wang J , Gao Y , Cheng B , Kanwore K , et al . Doublecor‑tin undergo nucleocytoplasmic transport via the rangtpase signaling to promote glioma progression . Cell Commun Signal . 2020 ; 18 ( 1 ): 24 .

Szymańska‑Chabowska A , Świątkowski F , Jankowska‑Polańska B , Mazur G , Chabowski M . Nestin expression as a diagnostic and prognostic marker in colorectal cancer and other tumors . Clin Med Insights Oncol . 2021 ; 15 : 11795549211038256 .

Mauffrey P , Tchitchek N , Barroca V , Bemelmans AP , Firlej V , Allory Y , et al . Progenitors from the central nervous system drive neurogenesis in cancer . Nature . 2019 ; 569 ( 7758 ): 672 – 8 .

Silverman DA , Martinez VK , Dougherty PM , Myers JN , Calin GA , Amit M . Cancer‑associated neurogenesis and nerve‑cancer cross‑talk . Cancer Res . 2021 ; 81 ( 6 ): 1431 – 40 .

Lu R , Fan C , Shangguan W , Liu Y , Li Y , Shang Y , et al . Neurons generated from carcinoma stem cells support cancer progression . Signal Trans‑duct Target Ther . 2017 ; 2 : 16036 .

Wang J , Chen Y , Li X , Zou X . Perineural invasion and associated pain transmission in pancreatic cancer . Cancers (Basel) . 2021 ; 13 ( 18 ): 4594 .

Cai Z , Yao H , Chen J , Ahmed AA , Li C , Hu X , et al . Schwann cells in pan‑creatic cancer: unraveling their multifaceted roles in tumorigenesis and neural interactions . Cancer Lett . 2024 ; 587 : 216689 .

Ni B , Yin Y , Li Z , Wang J , Wang X , Wang K . Crosstalk between peripheral innervation and pancreatic ductal adenocarcinoma . Neurosci Bull . 2023 ; 39 ( 11 ): 1717 – 31 .

Li J , Kang R , Tang D . Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma . Cancer Commun . 2021 ; 41 ( 8 ): 642 – 60 .

Ayala G . Neuroepithelial interactions in cancer . Annu Rev Pathol . 2023 ; 18 : 493 – 514 .

Zorick TS , Lemke G . Schwann cell differentiation . Curr Opin Cell Biol . 1996 ; 8 ( 6 ): 870 – 6 .

Deborde S , Wong RJ . How schwann cells facilitate cancer progression in nerves . Cell Mol Life Sci . 2017 ; 74 ( 24 ): 4405 – 20 .

Bosch‑Queralt M , Fledrich R , Stassart RM . Schwann cell func‑tions in peripheral nerve development and repair . Neurobiol Dis . 2023 ; 176 : 105952 .

Jessen KR , Mirsky R , Lloyd AC . Schwann cells: development and role in nerve repair . Cold Spring Harb Perspect Biol . 2015 ; 7 ( 7 ): a020487 .

Chen Z , Fang Y , Jiang W . Important cells and factors from tumor microenvironment participated in perineural invasion . Cancers (Basel) . 2023 ; 15 ( 5 ): 1360 .

Rangel‑Sosa MM , Mann F , Chauvet S . Pancreatic schwann cell repro‑gramming supports cancer‑associated neuronal remodeling . Glia . 2024 ; 72 ( 10 ): 1840 – 61 .

Dong Z , Wang Y , Jin W . The neuroscience of cancer: focus on neuropep‑tidergic systems . Acta Pharm Sin B . 2025 ; 15 ( 5 ): 2323 – 50 .

Moody TW , Chan D , Fahrenkrug J , Jensen RT . Neuropeptides as auto‑crine growth factors in cancer cells . Curr Pharm Des . 2003 ; 9 ( 6 ): 495 – 509 .

Deganutti G , Atanasio S , Rujan RM , Sexton PM , Wootten D , Reynolds CA . Exploring ligand binding to calcitonin gene‑related peptide receptors . Front Mol Biosci . 2021 ; 8 : 720561 .

Barwell J , Wootten D , Simms J , Hay DL , Poyner DR . Ramps and cgrp receptors . Adv Exp Med Biol . 2012 ; 744 : 13 – 24 .

Zhu W , Sheng D , Shao Y , Zhang Q , Peng Y . Neuronal calcitonin gene‑related peptide promotes prostate tumor growth in the bone microen‑vironment . Peptides . 2021 ; 135 : 170423 .

Venkatesh HS , Johung TB , Caretti V , Noll A , Tang Y , Nagaraja S , et al . Neu‑ronal activity promotes glioma growth through neuroligin‑3 secretion . Cell . 2015 ; 161 ( 4 ): 803 – 16 .

Venkatesh HS , Tam LT , Woo PJ , Lennon J , Nagaraja S , Gillespie SM , et al . Targeting neuronal activity‑regulated neuroligin‑3 dependency in high‑grade glioma . Nature . 2017 ; 549 ( 7673 ): 533 – 7 .

Khanmammadova N , Islam S , Sharma P , Amit M . Neuro‑immune inter‑actions and immuno‑oncology . Trends Cancer . 2023 ; 9 ( 8 ): 636 – 49 .

Jin H , Li M , Jeong E , Castro‑Martinez F , Zuker CS . A body‑brain circuit that regulates body inflammatory responses . Nature . 2024 ; 630 ( 8017 ): 695 – 703 .

Elenkov IJ , Wilder RL , Chrousos GP , Vizi ES . The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system . Pharmacol Rev . 2000 ; 52 ( 4 ): 595 – 638 .

Huang S , Ziegler CGK , Austin J , Mannoun N , Vukovic M , Ordovas‑Montanes J , et al . Lymph nodes are innervated by a unique popula‑tion of sensory neurons with immunomodulatory potential . Cell . 2021 ; 184 ( 2 ): 441 – 59.e25 .

Cole SW , Nagaraja AS , Lutgendorf SK , Green PA , Sood AK . Sympathetic nervous system regulation of the tumor microenvironment . Nat Rev Cancer . 2015 ; 15 ( 9 ): 563 – 72 .

Thapa S , Cao X . Nervous regulation: beta‑2‑adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases . Cancer Immunol Immunother . 2023 ; 72 ( 8 ): 2549 – 56 .

Faulkner S , Jobling P , March B , Jiang CC , Hondermarck H . Tumor neurobiology and the war of nerves in cancer . Cancer Discov . 2019 ; 9 ( 6 ): 702 – 10 .

Dong Z , Hou L , Luo W , Pan LH , Li X , Tan HP , et al . Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis . Eur Heart J . 2024 ; 45 ( 9 ): 669 – 84 .

Godiyal Y , Maheshwari D , Taniguchi H , Zinzuwadia SS , Morera‑Díaz Y , Tewari D , et al . Role of PD‑1/PD‑L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy . Mil Med Res . 2024 ; 11 ( 1 ): 82 .

Dutta P , Courties G , Wei Y , Leuschner F , Gorbatov R , Robbins CS , et al . Myocardial infarction accelerates atherosclerosis . Nature . 2012 ; 487 ( 7407 ): 325 – 9 .

Campbell JP , Karolak MR , Ma Y , Perrien DS , Masood‑Campbell SK , Penner NL , et al . Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice . PLoS Biol . 2012 ; 10 ( 7 ): e1001363 .

Partecke LI , Käding A , Trung DN , Diedrich S , Sendler M , Weiss F , et al . Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model . Oncotarget . 2017 ; 8 ( 14 ): 22501 – 12 .

Renz BW , Tanaka T , Sunagawa M , Takahashi R , Jiang Z , Macchini M , et al . Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness . Cancer Discov . 2018 ; 8 ( 11 ): 1458 – 73 .

Renz BW , Takahashi R , Tanaka T , Macchini M , Hayakawa Y , Dantes Z , et al . Β2 adrenergic‑neurotrophin feedforward loop promotes pancreatic cancer . Cancer Cell . 2018 ; 33 ( 1 ): 75 – 90.e7 .

Stopczynski RE , Normolle DP , Hartman DJ , Ying H , DeBerry JJ , Bielefeldt K , et al . Neuroplastic changes occur early in the development of pan‑creatic ductal adenocarcinoma . Cancer Res . 2014 ; 74 ( 6 ): 1718 – 27 .

Schwartz ES , La JH , Scheff NN , Davis BM , Albers KM , Gebhart GF . TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis . J Neurosci . 2013 ; 33 ( 13 ): 5603 – 11 .

James JM , Mukouyama YS . Neuronal action on the developing blood vessel pattern . Semin Cell Dev Biol . 2011 ; 22 ( 9 ): 1019 – 27 .

Shalabi S , Belayachi A , Larrivée B . Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment . Front Immunol . 2024 ; 15 : 1284629 .

Zahalka AH , Arnal‑Estapé A , Maryanovich M , Nakahara F , Cruz CD , Finley LWS , et al . Adrenergic nerves activate an angio‑metabolic switch in prostate cancer . Science . 2017 ; 358 ( 6361 ): 321 – 6 .

Thaker PH , Han LY , Kamat AA , Arevalo JM , Takahashi R , Lu C , et al . Author correction: chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma . Nat Med . 2021 ; 27 ( 12 ): 2246 .

Li Y , Liu F , Cai Q , Deng L , Ouyang Q , Zhang XH , et al . Invasion and metastasis in cancer: molecular insights and therapeutic targets . Signal Transduct Target Ther . 2025 ; 10 ( 1 ): 57 .

Ly T , Harihar S , Welch DR . KISS1 in metastatic cancer research and treatment: potential and paradoxes . Cancer Metastasis Rev . 2020 ; 39 ( 3 ): 739 – 54 .

Kalpana G , Figy C , Yeung M , Yeung KC . Reduced rhoa expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling . Sci Rep . 2019 ; 9 ( 1 ): 16351 .

Goertzen CG , Dragan M , Turley E , Babwah AV , Bhattacharya M . KISS1R signaling promotes invadopodia formation in human breast cancer cell via β‑arrestin2/ERK . Cell Signal . 2016 ; 28 ( 3 ): 165 – 76 .

Magnon C , Hall SJ , Lin J , Xue X , Gerber L , Freedland SJ , et al . Autonomic nerve development contributes to prostate cancer progression . Sci‑ence . 2013 ; 341 ( 6142 ): 1236361 .

Zhao J , Cheng L , Yang J , Xu F , Qi W , Liao K , et al . Tumor‑nerve interactions in cancer regulation and progression . Cancer Lett . 2025 ; 612 : 217483 .

Erin N , Zhao W , Bylander J , Chase G , Clawson G . Capsaicin‑induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells . Breast Cancer Res Treat . 2006 ; 99 ( 3 ): 351 – 64 .

Yang DQ , Freund DM , Harris BR , Wang D , Cleary MP , Hegeman AD . Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination . FEBS Lett . 2016 ; 590 ( 18 ): 3179 – 87 .

Caragher SP , Shireman JM , Huang M , Miska J , Atashi F , Baisiwala S , et al . Activation of dopamine receptor 2 prompts transcriptomic and meta‑bolic plasticity in glioblastoma . J Neurosci . 2019 ; 39 ( 11 ): 1982 – 93 .

Pavlova NN , Zhu J , Thompson CB . The hallmarks of cancer metabolism: still emerging . Cell Metab . 2022 ; 34 ( 3 ): 355 – 77 .

Fitzgerald PJ . Norepinephrine release may play a critical role in the Warburg effect: an integrative model of tumorigenesis . Neoplasma . 2020 ; 67 ( 5 ): 947 – 57 .

Qiao G , Chen M , Mohammadpour H , MacDonald CR , Bucsek MJ , Hylander BL , et al . Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor micro‑environment . Cancer Immunol Res . 2021 ; 9 ( 6 ): 651 – 64 .

Lamboy‑Caraballo R , Ortiz‑Sanchez C , Acevedo‑Santiago A , Matta J , Monteiro A , Armaiz‑Pena G . Norepinephrine‑induced DNA damage in ovarian cancer cells . Int J Mol Sci . 2020 ; 21 ( 6 ): 2250 .

Krishna S , Hervey‑Jumper SL . Neural regulation of cancer: cancer‑induced remodeling of the central nervous system . Adv Biol . 2022 ; 6 ( 9 ): e2200047 .

Venkatesh HS , Morishita W , Geraghty AC , Silverbush D , Gillespie SM , Arzt M , et al . Electrical and synaptic integration of glioma into neural circuits . Nature . 2019 ; 573 ( 7775 ): 539 – 45 .

Venkataramani V , Tanev DI , Strahle C , Studier‑Fischer A , Fankhauser L , Kessler T , et al . Glutamatergic synaptic input to glioma cells drives brain tumour progression . Nature . 2019 ; 573 ( 7775 ): 532 – 8 .

Folkman J . Angiogenesis: an organizing principle for drug discovery? . Nat Rev Drug Discov . 2007 ; 6 ( 4 ): 273 – 86 .

Zeng Q , Michael IP , Zhang P , Saghafinia S , Knott G , Jiao W , et al . Synaptic proximity enables NMDAR signalling to promote brain metastasis . Nature . 2019 ; 573 ( 7775 ): 526 – 31 .

Tan R , Wang F , Zhou Y , Huang Z , An Z , Xu Y . Neural functions in cancer: data analyses and database construction . Front Genet . 2023 ; 14 : 1062052 .

Balood M , Ahmadi M , Eichwald T , Ahmadi A , Majdoubi A , Roversi K , et al . Nociceptor neurons affect cancer immunosurveillance . Nature . 2022 ; 611 ( 7935 ): 405 – 12 .

Kamiya A , Hiyama T , Fujimura A , Yoshikawa S . Sympathetic and para‑sympathetic innervation in cancer: therapeutic implications . Clin Auton Res . 2021 ; 31 ( 2 ): 165 – 78 .

Yu Y , Hai Y , Zhou H , Bao W , Hu X , Gao Y , et al . Mettl3 inhibition sup‑presses cell growth and survival in colorectal cancer via ASNS downreg‑ulation . J Cancer . 2024 ; 15 ( 15 ): 4853 – 65 .

Wang W , Gong Z , Wang K , Tian M , Zhang Y , Li X , et al . Activation of the BMP2‑SMAD1‑CGRP pathway in dorsal root ganglia contributes to bone cancer pain in a rat model . Heliyon . 2024 ; 10 ( 6 ): e27350 .

van de Lisdonk D , Li B . The area postrema: a critical mediator of brain‑body interactions . Genes Dev . 2024 ; 38 ( 17–20 ): 793 – 7 .

Sun Q , van de Lisdonk D , Ferrer M , Gegenhuber B , Wu M , Park Y , et al . Area postrema neurons mediate interleukin‑6 function in cancer cachexia . Nat Commun . 2024 ; 15 ( 1 ): 4682 .

Reavis HD , Gysler SM , McKenney GB , Knarr M , Lusk HJ , Rawat P , et al . Norepinephrine induces anoikis resistance in high‑grade serous ovarian cancer precursor cells . JCI Insight . 2024 ; 9 ( 5 ): e170961 .

Hou CH , Chen WL , Lin CY . Targeting nerve growth factor‑mediated osteosarcoma metastasis: mechanistic insights and therapeutic oppor‑tunities using larotrectinib . Cell Death Dis . 2024 ; 15 ( 5 ): 381 .

He XY , Gao Y , Ng D , Michalopoulou E , George S , Adrover JM , et al . Chronic stress increases metastasis via neutrophil‑mediated changes to the microenvironment . Cancer Cell . 2024 ; 42 ( 3 ): 474 – 86.e12 .

Cheng K , Pan J , Liu Q , Ji Y , Liu L , Guo X , et al . Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR‑211‑5p/GDNF . Oncogene . 2024 ; 43 ( 18 ): 1341 – 52 .

Xiong SY , Wen HZ , Dai LM , Lou YX , Wang ZQ , Yi YL , et al . A brain‑tumor neural circuit controls breast cancer progression in mice . J Clin Invest . 2023 ; 133 ( 24 ): e167725 .

Wang X , Istvanffy R , Ye L , Teller S , Laschinger M , Diakopoulos KN , et al . Phenotype screens of murine pancreatic cancer identify a Tgf‑α‑CCL2‑paxillin axis driving human‑like neural invasion . J Clin Invest . 2023 ; 133 ( 21 ): e166333 .

Wang L , Duan Y , Lu S , Sun J . Magnetic nanomaterials mediate elec‑tromagnetic stimulations of nerves for applications in stem cell and cancer treatments . J Funct Biomater . 2023 ; 14 ( 2 ): 58 .

Taylor KR , Barron T , Hui A , Spitzer A , Yalçin B , Ivec AE , et al . Glioma synapses recruit mechanisms of adaptive plasticity . Nature . 2023 ; 623 ( 7986 ): 366 – 74 .

Li YT , Yuan WZ , Jin WL . Vagus innervation in the gastrointestinal tumor: current understanding and challenges . Biochimica et Biophysica Acta (BBA) . 2023 ; 1878 ( 3 ): 188884 .

Li F , He C , Yao H , Zhao Y , Ye X , Zhou S , et al . Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA‑m6A modification . Pharmacol Res . 2023 ; 187 : 106555 .

Huang D , Alexander PB , Li QJ , Wang XF . GABAergic signaling beyond synapses: an emerging target for cancer therapy . Trends Cell Biol . 2023 ; 33 ( 5 ): 403 – 12 .

Cui Q , Jiang D , Zhang Y , Chen C . The tumor‑nerve circuit in breast cancer . Cancer Metastasis Rev . 2023 ; 42 ( 2 ): 543 – 74 .

Vats K , Kruglov O , Sahoo B , Soman V , Zhang J , Shurin GV , et al . Sensory nerves impede the formation of tertiary lymphoid structures and development of protective antimelanoma immune responses . Cancer Immunol Res . 2022 ; 10 ( 9 ): 1141 – 54 .

Tang PC , Chung JY , Liao J , Chan MK , Chan AS , Cheng G , et al . Single‑cell RNA sequencing uncovers a neuron‑like macrophage subset associ‑ated with cancer pain . Sci Adv . 2022 ; 8 ( 40 ): eabn5535 .

Numan T , Breedt LC , Maciel B , Kulik SD , Derks J , Schoonheim MM , et al . Regional healthy brain activity, glioma occurrence, and symptomatol‑ogy . Brain . 2022 ; 145 ( 10 ): 3654 – 65 .

Chen P , Wang W , Liu R , Lyu J , Zhang L , Li B , et al . Olfactory sensory experience regulates gliomagenesis via neuronal IGF1 . Nature . 2022 ; 606 ( 7914 ): 550 – 6 .

Anastasaki C , Mo J , Chen JK , Chatterjee J , Pan Y , Scheaffer SM , et al . Neu‑ronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis‑1 . Nat Commun . 2022 ; 13 ( 1 ): 2785 .

Zhang M , Zheng M , Dai L , Zhang WL , Fan HY , Yu XH , et al . CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma . J Cell Mol Med . 2021 ; 25 ( 16 ): 7901 – 12 .

Yoneda T , Hiasa M , Okui T , Hata K . Sensory nerves: a driver of the vicious cycle in bone metastasis? . J Bone Oncol . 2021 ; 30 : 100387 .

Ren J , He J , Zhang H , Xia Y , Hu Z , Loughran P , et al . Platelet TLR4‑ERK5 axis facilitates net‑mediated capturing of circulating tumor cells and distant metastasis after surgical stress . Cancer Res . 2021 ; 81 ( 9 ): 2373 – 85 .

Liu S , Wang Z , Su Y , Qi L , Yang W , Fu M , et al . A neuroanatomical basis for electroacupuncture to drive the vagal‑adrenal axis . Nature . 2021 ; 598 ( 7882 ): 641 – 5 .

De Logu F , Marini M , Landini L , Souza Monteiro de Araujo D , Bar‑talucci N , Trevisan G , et al . Peripheral nerve resident macrophages and schwann cells mediate cancer‑induced pain . Cancer Res . 2021 ; 81 ( 12 ): 3387 – 401 .

Tian A , Kang B , Li B , Qiu B , Jiang W , Shao F , et al . Oncogenic state and cell identity combinatorially dictate the susceptibility of cells within glioma development hierarchy to IGF1R targeting . Adv Sci . 2020 ; 7 ( 21 ): 2001724 .

Middleton EA , He XY , Denorme F , Campbell RA , Ng D , Salvatore SP , et al . Neutrophil extracellular traps contribute to immunothrom‑bosis in COVID‑19 acute respiratory distress syndrome . Blood . 2020 ; 136 ( 10 ): 1169 – 79 .

Guo X , Pan Y , Xiong M , Sanapala S , Anastasaki C , Cobb O , et al . Midkine activation of CD8 + T cells establishes a neuron‑immune‑cancer axis responsible for low‑grade glioma growth . Nat Commun . 2020 ; 11 ( 1 ): 2177 .

Faulkner S , Griffin N , Rowe CW , Jobling P , Lombard JM , Oliveira SM , et al . Nerve growth factor and its receptor tyrosine kinase trka are overexpressed in cervical squamous cell carcinoma . FASEB Bioadv . 2020 ; 2 ( 7 ): 398 – 408 .

Cervantes‑Villagrana RD , Albores‑García D , Cervantes‑Villagrana AR , García‑Acevez SJ . Tumor‑induced neurogenesis and immune evasion as targets of innovative anti‑cancer therapies . Signal Transduct Target Ther . 2020 ; 5 ( 1 ): 99 .

Zuazo‑Gaztelu I , Pàez‑Ribes M , Carrasco P , Martín L , Soler A , Martínez‑Lozano M , et al . Antitumor effects of anti‑semaphorin 4D antibody unravel a novel proinvasive mechanism of vascular‑targeting agents . Cancer Res . 2019 ; 79 ( 20 ): 5328 – 41 .

Yang H , Xia L , Chen J , Zhang S , Martin V , Li Q , et al . Stress‑glucocorti‑coid‑TSC22D3 axis compromises therapy‑induced antitumor immunity . Nat Med . 2019 ; 25 ( 9 ): 1428 – 41 .

Wong SK , Mohamad NV , Giaze TR , Chin KY , Mohamed N , Ima‑Nirwana S . Prostate cancer and bone metastases: the underlying mechanisms . Int J Mol Sci . 2019 ; 20 ( 10 ): 2587 .

Shurin GV , Kruglov O , Ding F , Lin Y , Hao X , Keskinov AA , et al . Melanoma‑induced reprogramming of schwann cell signaling aids tumor growth . Cancer Res . 2019 ; 79 ( 10 ): 2736 – 47 .

Shuboni‑Mulligan DD , Breton G , Smart D , Gilbert M , Armstrong TS . Radiation chronotherapy‑clinical impact of treatment time‑of‑day: a systematic review . J Neurooncol . 2019 ; 145 ( 3 ): 415 – 27 .

Reinke H , Asher G . Crosstalk between metabolism and circadian clocks . Nat Rev Mol Cell Biol . 2019 ; 20 ( 4 ): 227 – 41 .

Obradović MMS , Hamelin B , Manevski N , Couto JP , Sethi A , Coissieux MM , et al . Glucocorticoids promote breast cancer metastasis . Nature . 2019 ; 567 ( 7749 ): 540 – 4 .

Martyn GV , Shurin GV , Keskinov AA , Bunimovich YL , Shurin MR . Schwann cells shape the neuro‑immune environs and control cancer progression . Cancer Immunol Immunother . 2019 ; 68 ( 11 ): 1819 – 29 .

Wakabayashi H , Wakisaka S , Hiraga T , Hata K , Nishimura R , Tominaga M , et al . Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1‑deficient mice . J Bone Miner Metab . 2018 ; 36 ( 3 ): 274 – 85 .

Liu L , Zhu Y , Noë M , Li Q , Pasricha PJ . Neuronal transforming growth factor beta signaling via SMAD3 contributes to pain in animal models of chronic pancreatitis . Gastroenterology . 2018 ; 154 ( 8 ): 2252 – 65.e2 .

Zhang Y , Sui F , Ma J , Ren X , Guan H , Yang Q , et al . Positive feedback loops between NRCAM and major signaling pathways contribute to thyroid tumorigenesis . J Clin Endocrinol Metab . 2017 ; 102 ( 2 ): 613 – 24 .

Maddocks ODK , Athineos D , Cheung EC , Lee P , Zhang T , van den Broek NJF , et al . Modulating the therapeutic response of tumours to dietary serine and glycine starvation . Nature . 2017 ; 544 ( 7650 ): 372 – 6 .

Li Z , Dong J , Zou T , Du C , Li S , Chen C , et al . Dexamethasone induces docetaxel and cisplatin resistance partially through up‑regulating Krüppel‑like factor 5 in triple‑negative breast cancer . Oncotarget . 2017 ; 8 ( 7 ): 11555 – 65 .

Hegemann M , Maas M , Rausch S , Walz S , Bedke J , Stenzl A , et al . Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer . Asian J Androl . 2017 ; 21 ( 1 ): 12 – 8 .

Cain DW , Cidlowski JA . Immune regulation by glucocorticoids . Nat Rev Immunol . 2017 ; 17 ( 4 ): 233 – 47 .

Boerboom A , Dion V , Chariot A , Franzen R . Molecular mechanisms involved in schwann cell plasticity . Front Mol Neurosci . 2017 ; 10 : 38 .

Jessen KR , Mirsky R . The repair schwann cell and its function in regener‑ating nerves . J Physiol . 2016 ; 594 ( 13 ): 3521 – 31 .

Wculek SK , Malanchi I . Neutrophils support lung colonization of metastasis‑initiating breast cancer cells . Nature . 2015 ; 528 ( 7582 ): 413 – 7 .

Kanojia D , Morshed RA , Zhang L , Miska JM , Qiao J , Kim JW , et al . Βiii‑tubulin regulates breast cancer metastases to the brain . Mol Cancer Ther . 2015 ; 14 ( 5 ): 1152 – 61 .

Casbon AJ , Reynaud D , Park C , Khuc E , Gan DD , Schepers K , et al . Inva‑sive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils . Proc Natl Acad Sci U S A . 2015 ; 112 ( 6 ): E566 – 75 .

Campbell SL , Robel S , Cuddapah VA , Robert S , Buckingham SC , Kahle KT , et al . GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor‑associated epilepsy . Glia . 2015 ; 63 ( 1 ): 23 – 36 .

Xiang HB , Liu C , Liu TT , Xiong J . Central circuits regulating the sympa‑thetic outflow to lumbar muscles in spinally transected mice by retro‑grade transsynaptic transport . Int J Clin Exp Pathol . 2014 ; 7 ( 6 ): 2987 – 97 .

Neman J , Termini J , Wilczynski S , Vaidehi N , Choy C , Kowolik CM , et al . Human breast cancer metastases to the brain display GABAergic prop‑erties in the neural niche . Proc Natl Acad Sci U S A . 2014 ; 111 ( 3 ): 984 – 9 .

Marik PE , Bellomo R . Stress hyperglycemia: an essential survival response! Crit Care Med . 2013 ; 41 ( 6 ): e93 – 4 .

Flandreau EI , Bourke CH , Ressler KJ , Vale WW , Nemeroff CB , Owens MJ . Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin‑releasing factor from the central amygdala . Psychoneuroendocrinology . 2013 ; 38 ( 8 ): 1349 – 61 .

Demir IE , Schorn S , Schremmer‑Danninger E , Wang K , Kehl T , Giese NA , et al . Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis . PLoS ONE . 2013 ; 8 ( 3 ): e60529 .

Cools‑Lartigue J , Spicer J , McDonald B , Gowing S , Chow S , Giannias B , et al . Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis . J Clin Invest . 2013 ; 123 ( 8 ): 3446 – 58 .

Erin N , Duymuş O , Oztürk S , Demir N . Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis . Regul Pept . 2012 ; 179 ( 1–3 ): 101 – 8 .

Adriaenssens E , Vanhecke E , Saule P , Mougel A , Page A , Romon R , et al . Nerve growth factor is a potential therapeutic target in breast cancer . Cancer Res . 2008 ; 68 ( 2 ): 346 – 51 .

Sève P , Lai R , Ding K , Winton T , Butts C , Mackey J , et al . Class III beta‑tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non‑small cell lung cancer: analysis of NCIC JBR.10 . Clin Cancer Res . 2007 ; 13 ( 3 ): 994 – 9 .

Anand U , Otto WR , Casula MA , Day NC , Davis JB , Bountra C , et al . The effect of neurotrophic factors on morphology, TRPV1 expression, and capsaicin responses of cultured human DRG sensory neurons . Neurosci Lett . 2006 ; 399 ( 1–2 ): 51 – 6 .

Douma S , Van Laar T , Zevenhoven J , Meuwissen R , Van Garderen E , Peeper DS . Suppression of anoikis and induction of metastasis by the neurotrophic receptor TRKB . Nature . 2004 ; 430 ( 7003 ): 1034 – 9 .

Ulloa L . Bioelectronic neuro‑immunology: neuronal networks for sym‑pathetic‑splenic and vagal‑adrenal control . Neuron . 2023 ; 111 ( 1 ): 10 – 4 .

Holtkamp SJ , Ince LM , Barnoud C , Schmitt MT , Sinturel F , Pilorz V , et al . Circadian clocks guide dendritic cells into skin lymphatics . Nat Immu‑nol . 2021 ; 22 ( 11 ): 1375 – 81 .

Gomez A , Wu Y , Zhang C , Boyd L , Wee TL , Gewolb J , et al . A brain‑body feedback loop driving HPA‑axis dysfunction in breast cancer . bioRxiv . 2024 .

Zheng Y , Li L , Shen Z , Wang L , Niu X , Wei Y , et al . Mechanisms of neural infiltration‑mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non‑small cell lung cancer . J Exp Clin Can‑cer Res . 2024 ; 43 ( 1 ): 284 .

Infante J , Burris H , Lewis N , Donehower R , Redman J , Friedman S , et al . A multicenter phase Ib study of the safety, pharmacokinetics, biological activity, and clinical efficacy of INCB7839, a potent and selective inhibi‑tor of ADAM10 and ADAM17 . Breast Cancer Res Treat . 2007 ; 106 . S269 .

Huang Q , Hu B , Zhang P , Yuan Y , Yue S , Chen X , et al . Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor, and the tumor immune microenvironment . Mol Cancer . 2025 ; 24 ( 1 ): 24 .

Ye Y , Xie T , Amit M . Targeting the nerve‑cancer circuit . Cancer Res . 2023 ; 83 ( 15 ): 2445 – 7 .

He D , Manzoni A , Florentin D , Fisher W , Ding Y , Lee M , et al . Biologic effect of neurogenesis in pancreatic cancer . Hum Pathol . 2016 ; 52 : 182 – 9 .

Lillemoe KD , Cameron JL , Kaufman HS , Yeo CJ , Pitt HA , Sauter PK . Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial . Ann Surg . 1993 ; 217 ( 5 ): 447 – 55 .

Prazeres P , Leonel C , Silva WN , Rocha BGS , Santos GSP , Costa AC , et al . Ablation of sensory nerves favours melanoma progression . J Cell Mol Med . 2020 ; 24 ( 17 ): 9574 – 89 .

Hayakawa Y , Sakitani K , Konishi M , Asfaha S , Niikura R , Tomita H , et al . Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling . Cancer Cell . 2017 ; 31 ( 1 ): 21 – 34 .

Kline CL , Van den Heuvel AP , Allen JE , Prabhu VV , Dicker DT , El‑Deiry WS . ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases . Sci Signal . 2016 ; 9 ( 415 ): ra18 .

Shi DD , Guo JA , Hoffman HI , Su J , Mino‑Kenudson M , Barth JL , et al . Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities . Lancet Oncol . 2022 ; 23 ( 2 ): e62 – 74 .

Ding Y , Lee M , Gao Y , Bu P , Coarfa C , Miles B , et al . Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resist‑ance . Prostate . 2021 ; 81 ( 1 ): 58 – 71 .

Jung J , Zhang Y , Celiku O , Zhang W , Song H , Williams BJ , et al . Mitochon‑drial NIX promotes tumor survival in the hypoxic niche of glioblastoma . Cancer Res . 2019 ; 79 ( 20 ): 5218 – 32 .

Afridi S , Muzzammil M , Ali I , Shahi MH . Neuropeptide signaling in glioblastoma: a comprehensive review of the current state and future direction . Neuromolecular Med . 2025 ; 27 ( 1 ): 27 .

Hetz C , Chevet E , Harding HP . Targeting the unfolded protein response in disease . Nat Rev Drug Discov . 2013 ; 12 ( 9 ): 703 – 19 .

Cascone T , McKenzie JA , Mbofung RM , Punt S , Wang Z , Xu C , et al . Increased tumor glycolysis characterizes immune resistance to adop‑tive T cell therapy . Cell Metab . 2018 ; 27 ( 5 ): 977 – 87.e4 .

Chang CH , Qiu J , O’Sullivan D , Buck MD , Noguchi T , Curtis JD , et al . Metabolic competition in the tumor microenvironment is a driver of cancer progression . Cell . 2015 ; 162 ( 6 ): 1229 – 41 .

Guo Y , Li Y , Su P , Yan M , Wang M , Li S , et al . Tumor microtubes: a new potential therapeutic target for high‑grade gliomas . J Neuropathol Exp Neurol . 2025 ; 84 ( 2 ): 93 – 103 .

Osswald M , Jung E , Sahm F , Solecki G , Venkataramani V , Blaes J , et al . Brain tumour cells interconnect to a functional and resistant network . Nature . 2015 ; 528 ( 7580 ): 93 – 8 .

Watson DC , Bayik D , Storevik S , Moreino SS , Sprowls SA , Han J , et al . GAP43‑dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity . Nat Cancer . 2023 ; 4 ( 5 ): 648 – 64 .

Yang J , Wu Y , Lv X , Liu S , Yuan Z , Chen Y , et al . Neurotransmitters: an emerging target for therapeutic resistance to tumor immune check‑point inhibitors . Mol Cancer . 2025 ; 24 ( 1 ): 216 .

Liu Y , Carlsson R , Ambjørn M , Hasan M , Badn W , Darabi A , et al . PD‑L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients . J Neurosci . 2013 ; 33 ( 35 ): 14231 – 45 .

Thielman NRJ , Funes V , Davuluri S , Ibanez HE , Sun WC , Fu J , et al . Semaphorin 3D promotes pancreatic ductal adenocarcinoma pro‑gression and metastasis through macrophage reprogramming . Sci Adv . 2024 ; 10 ( 42 ): eadp0684 .

Zhu J , Powis de Tenbossche CG , Cané S , Colau D , van Baren N , Lurquin C , et al . Resistance to cancer immunotherapy mediated by apoptosis of tumor‑infiltrating lymphocytes . Nat Commun . 2017 ; 8 ( 1 ): 1404 .

Xiong D , Zhang L , Sun ZJ . Targeting the epigenome to reinvigorate T cells for cancer immunotherapy . Mil Med Res . 2023 ; 10 ( 1 ): 59 .

Sierra JR , Corso S , Caione L , Cepero V , Conrotto P , Cignetti A , et al . Tumor angiogenesis and progression are enhanced by sema4D produced by tumor‑associated macrophages . J Exp Med . 2008 ; 205 ( 7 ): 1673 – 85 .

Tamagnone L , Franzolin G . Targeting semaphorin 4D in cancer: a look from different perspectives . Cancer Res . 2019 ; 79 ( 20 ): 5146 – 8 .

Zhang B , Wang S , Fu Z , Gao Q , Yang L , Lei Z , et al . Single‑cell RNA sequencing reveals intratumoral heterogeneity and potential mecha‑nisms of malignant progression in prostate cancer with perineural invasion . Front Genet . 2022 ; 13 : 1073232 .

Chambers CR , Watakul S , Schofield P , Howell AE , Zhu J , Tran AMH , et al . Targeting the NPY/NPY1R signaling axis in mutant p53‑dependent pancreatic cancer impairs metastasis . Sci Adv . 2025 ; 11 ( 11 ): eadq4416 .

Pascetta SA , Kirsh SM , Cameron M , Uniacke J . Pharmacological inhibi‑tion of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast can‑cer migration, proliferation, and signaling . BMC Cancer . 2023 ; 23 ( 1 ): 494 .

Shaikh M , Shirodkar S , Doshi G . Unraveling the role of perineural inva‑sion in cancer progression across multiple tumor types . Med Oncol . 2025 ; 42 ( 8 ): 283 .

Speyer CL , Hachem AH , Assi AA , Johnson JS , DeVries JA , Gorski DH . Metabotropic glutamate receptor‑1 as a novel target for the antiangio‑genic treatment of breast cancer . PLoS ONE . 2014 ; 9 ( 3 ): e88830 .

Hatipoglu G , Hock SW , Weiss R , Fan Z , Sehm T , Ghoochani A , et al . Sunitinib impedes brain tumor progression and reduces tumor‑induced neurodegeneration in the microenvironment . Cancer Sci . 2015 ; 106 ( 2 ): 160 – 70 .

Rabas N , Ferreira RMM , Di Blasio S , Malanchi I . Cancer‑induced systemic pre‑conditioning of distant organs: building a niche for metastatic cells . Nat Rev Cancer . 2024 ; 24 ( 12 ): 829 – 49 .

Krishna S , Choudhury A , Keough MB , Seo K , Ni L , Kakaizada S , et al . Glioblastoma remodelling of human neural circuits decreases survival . Nature . 2023 ; 617 ( 7961 ): 599 – 607 .

Buckingham SC , Campbell SL , Haas BR , Montana V , Robel S , Ogunrinu T , et al . Glutamate release by primary brain tumors induces epileptic activity . Nat Med . 2011 ; 17 ( 10 ): 1269 – 74 .

Calandre EP , Rico‑Villademoros F , Slim M . Alpha 2 delta ligands, gabapen‑tin, pregabalin, and mirogabalin: a review of their clinical pharmacology and therapeutic use . Expert Rev Neurother . 2016 ; 16 ( 11 ): 1263 – 77 .

Weller M , Stupp R , Wick W . Epilepsy meets cancer: when, why, and what to do about it? . Lancet Oncol . 2012 ; 13 ( 9 ): e375 – 82 .

Körber V , Yang J , Barah P , Wu Y , Stichel D , Gu Z , et al . Evolutionary trajectories of IDH wt glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis . Cancer Cell . 2019 ; 35 ( 4 ): 692 – 704.e12 .

Huberfeld G , Vecht CJ . Seizures and gliomas–towards a single therapeu‑tic approach . Nat Rev Neurol . 2016 ; 12 ( 4 ): 204 – 16 .

Curry RN , Ma Q , McDonald MF , Ko Y , Srivastava S , Chin PS , et al . Inte‑grated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma . Cancer Cell . 2024 ; 42 ( 10 ): 1713 – 28.e6 .

Stevens NA , Drewa N , Venkataramani V . Spark in the darkness: discover‑ing action potentials in brain tumors . Cancer Cell . 2024 ; 42 ( 10 ): 1645 – 7 .

Kerkhof M , Benit C , Duran‑Pena A , Vecht CJ . Seizures in oligodendroglial tumors . CNS Oncol . 2015 ; 4 ( 5 ): 347 – 56 .

Correia CE , Umemura Y , Flynn JR , Reiner AS , Avila EK . Pharmacoresist‑ant seizures and IDH mutation in low‑grade gliomas . Neurooncol Adv . 2021 ; 3 ( 1 ): vdab146 .

Bennett MI , Rayment C , Hjermstad M , Aass N , Caraceni A , Kaasa S . Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review . Pain . 2012 ; 153 ( 2 ): 359 – 65 .

Schmitd LB , Scanlon CS , D’Silva NJ . Perineural invasion in head and neck cancer . J Dent Res . 2018 ; 97 ( 7 ): 742 – 50 .

Zajączkowska R , Kocot‑Kępska M , Leppert W , Wordliczek J . Bone pain in cancer patients: mechanisms and current treatment . Int J Mol Sci . 2019 ; 20 ( 23 ): 6047 .

Shi RJ , Ke BW , Tang YL , Liang XH . Perineural invasion: a potential driver of cancer‑induced pain . Biochem Pharmacol . 2023 ; 215 : 115692 .

Mittal A , Sagi V , Gupta M , Gupta K . Mast cell neural interactions in health and disease . Front Cell Neurosci . 2019 ; 13 : 110 .

Gupta K , Harvima IT . Mast cell‑neural interactions contribute to pain and itch . Immunol Rev . 2018 ; 282 ( 1 ): 168 – 87 .

Jiang SH , Li RK , Liu DJ , Xue JL , Yu MH , Zhang S , et al . The genomic, transcriptomic, and immunological profiles of perineural invasion in pancreatic ductal adenocarcinoma . Sci China Life Sci . 2023 ; 66 ( 1 ): 183 – 6 .

Baruch EN , Nagarajan P , Gleber‑Netto FO , Rao X , Xie T , Akhter S , et al . Inflammation induced by tumor‑associated nerves promotes resistance to anti‑PD‑1 therapy in cancer patients and is targetable by interleu‑kin‑6 blockade . Res Sq . 2023 : rs.3.rs‑3161761 .

Zhang Y , Sang R , Bao J , Jiang Z , Qian D , Zhou Y , et al . Schwann cell‑derived CXCL2 contributes to cancer pain by modulating macrophage infiltration in a mouse breast cancer model . Brain Behav Immun . 2023 ; 109 : 308 – 20 .

Zhang Z , Lv ZG , Lu M , Li H , Zhou J . Nerve‑tumor crosstalk in tumor microenvironment: from tumor initiation and progression to clinical implications . Biochimica Biophysica Acta (BBA) . 2024 ; 1879 ( 4 ): 189121 .

Li H , Zhao L , Li J , Zhang K , Bai W , Chen Y . Neuron‑like macrophage differentiation via the APOE‑TREM2 axis contributes to chronic pain in nasopharyngeal carcinoma . Cell Biol Toxicol . 2025 ; 41 ( 1 ): 86 .

Hasegawa K , Okui T , Shimo T , Ibaragi S , Kawai H , Ryumon S , et al . Lactate transporter monocarboxylate transporter 4 induces bone pain in head and neck squamous cell carcinoma . Int J Mol Sci . 2018 ; 19 ( 11 ): 3317 .

Gao YM , Pei Y , Zhao FF , Wang L . Osteoclasts in osteosarcoma: mecha‑nisms, interactions, and therapeutic prospects . Cancer Manag Res . 2023 ; 15 : 1323 – 37 .

Zhang X , Yuan X , Li X , Yu H , Wang T , Zhang C , et al . Sodium danshensu alleviates bone cancer pain by inhibiting the osteoclast differentiation and CGRP expression . Eur J Pharmacol . 2025 ; 992 : 177296 .

Chen X , Gan Y , Au NPB , Ma CHE . Current understanding of the molecu‑lar mechanisms of chemotherapy‑induced peripheral neuropathy . Front Mol Neurosci . 2024 ; 17 : 1345811 .

Koyanagi M , Imai S , Matsumoto M , Iguma Y , Kawaguchi‑Sakita N , Kotake T , et al . Pronociceptive roles of schwann cell‑derived galectin‑3 in taxane‑induced peripheral neuropathy . Cancer Res . 2021 ; 81 ( 8 ): 2207 – 19 .

Sadler KE , Moehring F , Shiers SI , Laskowski LJ , Mikesell AR , Plautz ZR , et al . Transient receptor potential canonical 5 mediates inflammatory mechanical and spontaneous pain in mice . Sci Transl Med . 2021 ; 13 ( 595 ): eabd7702 .

Meerschaert KA , Edwards BS , Epouhe AY , Jefferson B , Friedman R , Babyok OL , et al . Neuronally expressed PDL1, not PD1, suppresses acute nociception . Brain Behav Immun . 2022 ; 106 : 233 – 46 .

Wanderley CWS , Maganin AGM , Adjafre B , Mendes AS , Silva CEA , Quadros AU , et al . PD‑1/PD‑L1 inhibition enhances chemotherapy‑induced neuropathic pain by suppressing neuroimmune antinocic‑eptive signaling . Cancer Immunol Res . 2022 ; 10 ( 11 ): 1299 – 308 .

Loprinzi CL , Lacchetti C , Bleeker J , Cavaletti G , Chauhan C , Hertz DL , et al . Prevention and management of chemotherapy‑induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update . J Clin Oncol . 2020 ; 38 ( 28 ): 3325 – 48 .

Sugimoto M , Takagi T , Suzuki R , Konno N , Asama H , Sato Y , et al . Miro‑gabalin vs pregabalin for chemotherapy‑induced peripheral neu‑ropathy in pancreatic cancer patients . BMC Cancer . 2021 ; 21 ( 1 ): 1319 .

Gu I , Gregory E , Atwood C , Lee SO , Song YH . Exploring the role of metabolites in cancer and the associated nerve crosstalk . Nutrients . 2022 ; 14 ( 9 ): 1722 .

Shankara Narayanan JSN , Frizzi K , Erdem S , Ray P , Jaroch D , Cox B , et al . Oxaliplatin‑induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model . Discov Oncol . 2022 ; 13 ( 1 ): 21 .

Chida Y , Hamer M , Wardle J , Steptoe A . Do stress‑related psychosocial factors contribute to cancer incidence and survival? . Nat Clin Pract Oncol . 2008 ; 5 ( 8 ): 466 – 75 .

Marzorati C , Voskanyan V , Sala D , Grasso R , Borgogni F , Pietrobon R , et al . Psychosocial factors associated with quality of life in cancer patients undergoing treatment: an umbrella review . Health Qual Life Outcomes . 2025 ; 23 ( 1 ): 31 .

Yan J , Chen Y , Luo M , Hu X , Li H , Liu Q , et al . Chronic stress in solid tumor development: from mechanisms to interventions . J Biomed Sci . 2023 ; 30 ( 1 ): 8 .

Li J , Che M , Zhang B , Zhao K , Wan C , Yang K . The association between the neuroendocrine system and the tumor immune microenviron‑ment: emerging directions for cancer immunotherapy . Biochimica Biophysica Acta (BBA) . 2023 ; 1878 ( 6 ): 189007 .

Khan A , Song M , Dong Z . Chronic stress: a fourth etiology in tumori‑genesis? . Mol Cancer . 2025 ; 24 ( 1 ): 196 .

Pundavela J , Roselli S , Faulkner S , Attia J , Scott RJ , Thorne RF , et al . Nerve fibers infiltrate the tumor microenvironment and are associ‑ated with nerve growth factor production and lymph node invasion in breast cancer . Mol Oncol . 2015 ; 9 ( 8 ): 1626 – 35 .

Ma Y , Kroemer G . The cancer‑immune dialogue in the context of stress . Nat Rev Immunol . 2024 ; 24 ( 4 ): 264 – 81 .

Stagl JM , Bouchard LC , Lechner SC , Blomberg BB , Gudenkauf LM , Jutagir DR , et al . Long‑term psychological benefits of cognitive‑behavioral stress management for women with breast cancer: 11‑year follow‑up of a randomized controlled trial . Cancer . 2015 ; 121 ( 11 ): 1873 – 81 .

Stagl JM , Lechner SC , Carver CS , Bouchard LC , Gudenkauf LM , Jutagir DR , et al . A randomized controlled trial of cognitive‑behavioral stress management in breast cancer: survival and recurrence at 11‑year follow‑up . Breast Cancer Res Treat . 2015 ; 154 ( 2 ): 319 – 28 .

Anghel T , Melania BL , Costea I , Albai O , Marinca A , Levai CM , et al . Review of psychological interventions in oncology: current trends and future directions . Medicina (Kaunas) . 2025 ; 61 ( 2 ): 279 .

Bower JE , Crosswell AD , Stanton AL , Crespi CM , Winston D , Arevalo J , et al . Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial . Cancer . 2015 ; 121 ( 8 ): 1231 – 40 .

Cramer H , Lauche R , Klose P , Lange S , Langhorst J , Dobos GJ . Yoga for improving health‑related quality of life, mental health and cancer‑related symptoms in women diagnosed with breast cancer . Cochrane Database Syst Rev . 2017 ; 1 ( 1 ): Cd010802 .

Schmid D , Leitzmann MF . Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a sys‑tematic review and meta‑analysis . Ann Oncol . 2014 ; 25 ( 7 ): 1293 – 311 .

Zhang Y , Sun Y , Li D , Liu X , Fang C , Yang C , et al . Acupuncture for breast cancer: a systematic review and meta‑analysis of patient‑reported outcomes . Front Oncol . 2021 ; 11 : 646315 .

Bozorgi A , Khazaei S , Khademi A , Khazaei M . Natural and herbal com‑pounds targeting breast cancer, a review based on cancer stem cells . Iran J Basic Med Sci . 2020 ; 23 ( 8 ): 970 – 83 .

Satpathi S , Gaurkar SS , Potdukhe A , Wanjari MB . Unveiling the role of hormonal imbalance in breast cancer development: a comprehensive review . Cureus . 2023 ; 15 ( 7 ): e41737 .

Borniger JC , Walker Ii WH , Surbhi , Emmer KM , Zhang N , Zalenski AA , et al . A role for hypocretin/orexin in metabolic and sleep abnormali‑ties in a mouse model of non‑metastatic breast cancer . Cell Metab . 2018 ; 28 ( 1 ): 118 – 295 .

Wang YF , Dong ZK , Jin WL . Hijacking homeostasis: the brain‑body neu‑ral circuitry in tumor pathogenesis and emerging therapeutic frontiers . Mol Cancer . 2025 ; 24 ( 1 ): 206 .

Pu T , Sun J , Ren G , Li H . Neuro‑immune crosstalk in cancer: mecha‑nisms and therapeutic implications . Signal Transduct Target Ther . 2025 ; 10 ( 1 ): 176 .

Papagiannakopoulos T , Bauer MR , Davidson SM , Heimann M , Subbaraj L , Bhutkar A , et al . Circadian rhythm disruption promotes lung tumori‑genesis . Cell Metab . 2016 ; 24 ( 2 ): 324 – 31 .

Chen X , Geng Y , Wei G , He D , Lv J , Wen W , et al . Neural circuit‑ries between the brain and peripheral solid tumors . Cancer Res . 2024 ; 84 ( 21 ): 3509 – 21 .

Wang Y , Dong Z , An Z , Jin W . Cancer cachexia: focus on cachexia factors and inter‑organ communication . Chin Med J (Engl) . 2024 ; 137 ( 1 ): 44 – 62 .

Jing H , Gao Y , Sun Z , Liu S . Recent advances in novel tumor immuno‑therapy strategies based on regulating the tumor microenvironment and immune checkpoints . Front Immunol . 2025 ; 16 : 1529403 .

Seicol BJ , Guo Z , Garrity K , Xie R . Potential uses of auditory nerve stimu‑lation to modulate immune responses in the inner ear and auditory brainstem . Front Integr Neurosci . 2023 ; 17 : 1294525 .

Brem S . Vagus nerve stimulation: novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin‑6) reduction, attenuating the sasp, enhancing tumor immunity . Brain Behav Immun . 2024 ; 42 : 100859 .

Liu S , Wang ZF , Su YS , Ray RS , Jing XH , Wang YQ , et al . Somatotopic organization and intensity dependence in driving distinct NPY‑expressing sympathetic pathways by electroacupuncture . Neuron . 2020 ; 108 ( 3 ): 436 – 50.e7 .

Torres‑Rosas R , Yehia G , Peña G , Mishra P , del Rocio Thompson‑Bonilla M , Moreno‑Eutimio MA , et al . Dopamine mediates vagal modulation of the immune system by electroacupuncture . Nat Med . 2014 ; 20 ( 3 ): 291 – 5 .

Li G , Jiang Y , Tong H , Liu J , Jiang Z , Zhao Y , et al . Sciatic nerve stimula‑tion enhances NK cell cytotoxicity through dopamine signaling and synergizes immunotherapy in triple‑negative breast cancer . Drug Resist Updat . 2025 ; 79 : 101212 .

Dubeykovskaya Z , Si Y , Chen X , Worthley DL , Renz BW , Urbanska AM , et al . Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer . Nat Commun . 2016 ; 7 : 10517 .

Stolk RF , van der Pasch E , Naumann F , Schouwstra J , Bressers S , van Her‑waarden AE , et al . Norepinephrine dysregulates the immune response and compromises host defense during sepsis . Am J Respir Crit Care Med . 2020 ; 202 ( 6 ): 830 – 42 .

Takashima Y , Hamano M , Yoshii K , Hayano A , Fukai J , Iwadate Y , et al . Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma . Int J Clin Oncol . 2023 ; 28 ( 3 ): 468 – 81 .

El‑Sayes N , Vito A , Mossman K . Tumor heterogeneity: a great barrier in the age of cancer immunotherapy . Cancers (Basel) . 2021 ; 13 ( 4 ): 806 .

Mayer EA , Nance K , Chen S . The gut‑brain axis . Annu Rev Med . 2022 ; 73 : 439 – 53 .

Nuevo‑Tapioles C , Santacatterina F , Stamatakis K , Núñez de Arenas C , Gómez de Cedrón M , Formentini L , et al . Coordinate β‑adrenergic inhi‑bition of mitochondrial activity and angiogenesis arrest tumor growth . Nat Commun . 2020 ; 11 ( 1 ): 3606 .

Jin MZ , Jin WL . The updated landscape of tumor microenvironment and drug repurposing . Signal Transduct Target Ther . 2020 ; 5 ( 1 ): 166 .

Dong ZK , Wang YF , Li WP , Jin WL . Neurobiology of cancer: adrenergic signaling and drug repurposing . Pharmacol Ther . 2024 ; 264 : 108750 .

Mathews J , Newcomer JW , Mathews JR , Fales CL , Pierce KJ , Akers BK , et al . Neural correlates of weight gain with olanzapine . Arch Gen Psy‑chiatry . 2012 ; 69 ( 12 ): 1226 – 37 .

Zhao C , Li M . Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c‑Fos immunore‑activity . Pharmacol Biochem Behav . 2012 ; 103 ( 2 ): 174 – 80 .

Chen P , Hsu WH , Chang A , Tan Z , Lan Z , Zhou A , et al . Circadian regulator clock recruits immune‑suppressive microglia into the GBM tumor microenvironment . Cancer Discov . 2020 ; 10 ( 3 ): 371 – 81 .

Lu J , Zhang X , Su K , Luo H , Liu C , Yang Y , et al . Olanzapine suppresses MPFC activity‑norepinephrine releasing to alleviate clock‑enhanced cancer stemness under chronic stress . Cell Commun Signal . 2024 ; 22 ( 1 ): 375 .

Sanomachi T , Suzuki S , Kuramoto K , Takeda H , Sakaki H , Togashi K , et al . Olanzapine, an atypical antipsychotic, inhibits survivin expression and sensitizes cancer cells to chemotherapeutic agents . Anticancer Res . 2017 ; 37 ( 11 ): 6177 – 88 .

Zhu Y , Zhao YF , Liu RS , Xiong YJ , Shen X , Wang Y , et al . Olanzapine induced autophagy through suppression of NF‑κB activation in human glioma cells . CNS Neurosci Ther . 2019 ; 25 ( 9 ): 911 – 21 .

Lee S , Weiss T , Bühler M , Mena J , Lottenbach Z , Wegmann R , et al . High‑throughput identification of repurposable neuroac‑tive drugs with potent anti‑glioblastoma activity . Nat Med . 2024 ; 30 ( 11 ): 3196 – 208 .

Venkataramani V , Yang Y , Schubert MC , Reyhan E , Tetzlaff SK , Wiß‑mann N , et al . Glioblastoma hijacks neuronal mechanisms for brain invasion . Cell . 2022 ; 185 ( 16 ): 2899 ‑ 917.e31 .

Weiss T , Schneider H , Silginer M , Steinle A , Pruschy M , Polić B , et al . NKG2D‑dependent antitumor effects of chemotherapy and radio‑therapy against glioblastoma . Clin Cancer Res . 2018 ; 24 ( 4 ): 882 – 95 .

Langford DJ , Bailey AL , Chanda ML , Clarke SE , Drummond TE , Echols S , et al . Coding of facial expressions of pain in the laboratory mouse . Nat Methods . 2010 ; 7 ( 6 ): 447 – 9 .

Sheng M , Thompson MA , Greenberg ME . Creb: a Ca 2+ ‑regulated tran‑scription factor phosphorylated by calmodulin‑dependent kinases . Science . 1991 ; 252 ( 5011 ): 1427 – 30 .

Whitmarsh AJ , Davis RJ . Transcription factor AP‑1 regulation by mitogen‑activated protein kinase signal transduction pathways . J Mol Med (Berl) . 1996 ; 74 ( 10 ): 589 – 607 .

Wang X , Li B , Kim YJ , Wang YC , Li Z , Yu J , et al . Targeting monoamine oxidase a for T cell‑based cancer immunotherapy . Sci Immunol . 2021 ; 6 ( 59 ): eabh2383 .

Coyle CM , Laws KR . The use of ketamine as an antidepressant: a sys‑tematic review and meta‑analysis . Hum Psychopharmacol Clin Exp . 2015 ; 30 ( 3 ): 152 – 63 .

Machado‑Vieira R , Henter ID , Jr Zarate CA . New targets for rapid antidepressant action . Prog Neurobiol . 2017 ; 152 : 21 – 37 .

Zhao J , Zhang R , Wang W , Jiang S , Liang H , Guo C , et al . Low‑dose ketamine inhibits neuronal apoptosis and neuroinflammation in PC12 cells via α7nAChR mediated TLR4/MAPK/NF‑κB signaling path‑way . Int Immunopharmacol . 2023 ; 117 : 109880 .

Liu X , Liu X , Mao W , Guo Y , Bai N , Jin L , et al . Tetrastigma polysaccha‑ride reprogramming of tumor‑associated macrophages via PPARγ signaling pathway to play antitumor activity in breast cancer . J Ethnopharmacol . 2023 ; 314 : 116645 .

Mehta AK , Kadel S , Townsend MG , Oliwa M , Guerriero JL . Macrophage biology and mechanisms of immune suppression in breast cancer . Front Immunol . 2021 ; 12 : 643771 .

Jiang Y , Li Y , Zhu B . T‑cell exhaustion in the tumor microenvironment . Cell Death Dis . 2015 ; 6 ( 6 ): e1792 .

Barron T , Yalçın B , Su M , Byun YG , Gavish A , Shamardani K , et al . Gabaergic neuron‑to‑glioma synapses in diffuse midline gliomas . Nature . 2025 ; 639 ( 8056 ): 1060 – 8 .

Ryu JY , Min KL , Chang MJ . Effect of anti‑epileptic drugs on the survival of patients with glioblastoma multiforme: a retrospective, single‑center study . PLoS ONE . 2019 ; 14 ( 12 ): e0225599 .

Gonzales CN , Negussie MB , Krishna S , Ambati VS , Hervey‑Jumper SL . Malignant glioma remodeling of neuronal circuits: therapeutic opportunities and repurposing of antiepileptic drugs . Trends Cancer . 2024 ; 10 ( 12 ): 1106 – 15 .

Albiñana V , Gallardo‑Vara E , Casado‑Vela J , Recio‑Poveda L , Botella LM , Cuesta AM . Propranolol: a “pick and roll” team player in benign tumors and cancer therapies . J Clin Med . 2022 ; 11 ( 15 ): 4539 .

Ren L , Xu X , Liu X , Ning H , Ding Q , Yang M , et al . Recent advances in propranolol hydrochloride formulations for the treatment of infantile hemangiomas . Drug Des Devel Ther . 2025 ; 19 : 1163 – 83 .

Hiller JG , Cole SW , Crone EM , Byrne DJ , Shackleford DM , Pang JB , et al . Preoperative β‑blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial . Clin Cancer Res . 2020 ; 26 ( 8 ): 1803 – 11 .

Liao P , Song K , Zhu Z , Liu Z , Zhang W , Li W , et al . Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8 + T cells and inhibiting tumor AKT/MAPK pathway . Clin Pharmacol Ther . 2020 ; 108 ( 3 ): 606 – 15 .

Padmanaban V , Keller I , Seltzer ES , Ostendorf BN , Kerner Z , Tavazoie SF . Neuronal substance P drives metastasis through an extracellular RNA‑TLR7 axis . Nature . 2024 ; 633 ( 8028 ): 207 – 15 .

Chandel V , Raj S , Kumar P , Gupta S , Dhasmana A , Kesari KK , et al . Metabolic regulation in HPV associated head and neck squamous cell carcinoma . Life Sci . 2020 ; 258 : 118236 .

Wilkie MD , Lau AS , Vlatkovic N , Jones TM , Boyd MT . Metabolic signature of squamous cell carcinoma of the head and neck: consequences of TP53 mutation and therapeutic perspectives . Oral Oncol . 2018 ; 83 : 1 – 10 .

Shin JM , Kamarajan P , Fenno JC , Rickard AH , Kapila YL . Metabolomics of head and neck cancer: a mini‑review . Front Physiol . 2016 ; 7 : 526 .

Voelxen NF , Blatt S , Knopf P , Henkel M , Appelhans C , Righesso LAR , et al . Comparative metabolic analysis in head and neck cancer and the normal gingiva . Clin Oral Investig . 2018 ; 22 ( 2 ): 1033 – 43 .

Zhang Y , Lin C , Liu Z , Sun Y , Chen M , Guo Y , et al . Cancer cells co‑opt nociceptive nerves to thrive in nutrient‑poor environments and upon nutrient‑starvation therapies . Cell Metab . 2022 ; 34 ( 12 ): 1999 – 2017.e10 .

Lu H , Zhang H , Weng ML , Zhang J , Jiang N , Cata JP , et al . Morphine pro‑motes tumorigenesis and cetuximab resistance via EGFR signaling acti‑vation in human colorectal cancer . J Cell Physiol . 2021 ; 236 ( 6 ): 4445 – 54 .

Lennon FE , Mirzapoiazova T , Mambetsariev B , Poroyko VA , Salgia R , Moss J , et al . The mu opioid receptor promotes opioid and growth factor‑induced proliferation, migration, and epithelial mesenchymal transition (EMT) in human lung cancer . PLoS ONE . 2014 ; 9 ( 3 ): e91577 .

Schito L . Hypoxia‑dependent angiogenesis and lymphangiogenesis in cancer . Adv Exp Med Biol . 2019 ; 1136 : 71 – 85 .

Xia Y , Sun M , Huang H , Jin WL . Drug repurposing for cancer therapy . Signal Transduct Target Ther . 2024 ; 9 ( 1 ): 92 .

Chehelgerdi M , Chehelgerdi M , Allela OQB , Pecho RDC , Jayasankar N , Rao DP , et al . Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation . Mol Cancer . 2023 ; 22 ( 1 ): 169 .

Lei Y , Hamada Y , Li J , Cong L , Wang N , Li Y , et al . Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparti‑cles to regulate pancreatic cancer progression . J Control Release . 2016 ; 232 : 131 – 42 .

Chu X , Zhuang H , Liu Y , Li J , Wang Y , Jiang Y , et al . Blocking cancer‑nerve crosstalk for treatment of metastatic bone cancer pain . Adv Mater . 2022 ; 34 ( 17 ): e2108653 .

Sun J , Wang D , Wei Y , Wang D , Ji Z , Sun W , et al . Capsaicin‑induced Ca 2+ overload and ablation of TRPV1‑expressing axonal terminals for comfortable tumor immunotherapy . Nanoscale . 2024 ; 17 ( 6 ): 3288 – 305 .

Bhansali D , Tu NH , Inoue K , Teng S , Li T , Tran HD , et al . PAR 2 on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle‑encapsulated AZ3451 . Biomaterials . 2025 ; 314 : 122874 .

Xu Y , Xu C , Song H , Feng X , Ma L , Zhang X , et al . Biomimetic bone‑periosteum scaffold for spatiotemporal regulated innervated bone regeneration and therapy of osteosarcoma . J Nanobiotechnology . 2024 ; 22 ( 1 ): 250 .

Zhang Q , Zhuang H , Wen X , Su Y , Wang J , Qin H , et al . Organelle remod‑eling enhances mitochondrial ATP disruption for blocking neuro‑pain signaling in bone tumor therapy . Chem Eng J . 2025 : 159825 .

Qin J , Liu J , Wei Z , Li X , Chen Z , Li J , et al . Targeted intervention in nerve‑cancer crosstalk enhances pancreatic cancer chemotherapy . Nat Nanotechnol . 2024 ; 20 ( 2 ): 311 – 24 .

Liang F , You Q , Yu B , Wang C , Yang Y , Zhu L , et al . Neurotransmitter‑mimicking nanovesicles facilitate postoperative glioblastoma stem cell‑specific treatment for preventing tumor recurrence . Adv Sci (Weinh) . 2024 : e2409713 .

Ding L , Tang S , Yu A , Wang A , Tang W , Jia H , et al . Nanoemulsion‑assisted siRNA delivery to modulate the nervous tumor microen‑vironment in the treatment of pancreatic cancer . ACS Appl Mater Interfaces . 2022 ; 14 ( 8 ): 10015 – 29 .

Ma GL , Lin WF . Immune checkpoint inhibition mediated with liposo‑mal nanomedicine for cancer therapy . Mil Med Res . 2023 ; 10 ( 1 ): 20 .

Kaduri M , Sela M , Kagan S , Poley M , Abumanhal‑Masarweh H , Mora‑Raimundo P , et al . Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases . Sci Adv . 2021 ; 7 ( 41 ): eabj5435 .

He J , Zhang X , Xing H , Tan J , Zhang L , Xu Z , et al . Nanoparticle‑mediated synergistic disruption of tumor innervation and redox homeostasis for potent antineoplastic therapy . J Control Release . 2024 ; 376 : 457 – 69 .

Zhou S , Li J , Yu J , Wang Y , Wang Z , He Z , et al . Tumor microenviron‑ment adrenergic nerves blockade liposomes for cancer therapy . J Control Release . 2022 ; 351 : 656 – 66 .

Yang C , He Y , Chen F , Zhang F , Shao D , Wang Z . Leveraging β‑adrenergic receptor signaling blockade for improved can‑cer immunotherapy through biomimetic nanovaccine . Small . 2023 ; 19 ( 14 ): e2207029 .

Singh AK , McGuirk JP . CAR T cells: continuation in a revolution of immu‑notherapy . Lancet Oncol . 2020 ; 21 ( 3 ): e168 – 78 .

Yang P , Chen X , Yu F , Wang L , Li M , Bai Z , et al . CAR T cells secreting ngf‑neutralizing SCFV enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy . J Immunother Cancer . 2024 ; 12 ( 12 ): e009910 .

Branella GM , Spencer HT . Natural receptor‑ and ligand‑based chimeric antigen receptors: strategies using natural ligands and receptors for targeted cell killing . Cells . 2021 ; 11 ( 1 ): 21 .

Ramírez‑Chacón A , Betriu‑Méndez S , Bartoló‑Ibars A , González A , Martí M , Juan M . Corrigendum: ligand‑based CAR T‑cell: different strategies to drive T‑cells in future new treatments . Front Immunol . 2022 ; 13 : 1078003 .

Khotskaya YB , Holla VR , Farago AF , Mills Shaw KR , Meric‑Bernstam F , Hong DS . Targeting TRK family proteins in cancer . Pharmacol Ther . 2017 ; 173 : 58 – 66 .

Liang D , Tang J , Sun B , He S , Yang D , Ma H , et al . Novel CAR‑T cells targeting TRKB for the treatment of solid cancer . Apoptosis . 2024 ; 29 ( 11–12 ): 2183 – 96 .

Chokshi CR , Shaikh MV , Brakel B , Rossotti MA , Tieu D , Maich W , et al . Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells . Nat Med . 2024 ; 30 ( 10 ): 2936 – 46 .

Di Carlo E , Sorrentino C . State of the ART CRISPR‑based strategies for cancer diagnostics and treatment . Biomark Res . 2024 ; 12 ( 1 ): 156 .

Galappaththi SL , Katz B , Howze PHt , Hoover G , Grelet S . A CRISPR/Cas9‑based assay for high‑throughput studies of cancer‑induced innerva‑tion . Cancers (Basel) . 2023 ; 15 ( 7 ): 2026 .

Sun Q , van de Lisdonk D , Ferrer M , Gegenhuber B , Wu M , Tollkuhn J , et al . Area postrema neurons mediate interleukin‑6 function in cancer‑associated cachexia . bioRxiv . 2023 : 2023.01.12.523716 .

Fang N , Gu T , Wang Y , Wang S , Wang F , An Y , et al . Expression of pten‑long mediated by CRISPR/Cas9 can repress U87 cell proliferation . J Cell Mol Med . 2017 ; 21 ( 12 ): 3337 – 46 .

Lino CA , Harper JC , Carney JP , Timlin JA . Delivering CRISPR: a review of the challenges and approaches . Drug Deliv . 2018 ; 25 ( 1 ): 1234 – 57 .

Pineda M , Lear A , Collins JP , Kiani S . Safe CRISPR: challenges and pos‑sible solutions . Trends Biotechnol . 2019 ; 37 ( 4 ): 389 – 401 .

Bedbrook CN , Deverman BE , Gradinaru V . Viral strategies for target‑ing the central and peripheral nervous systems . Annu Rev Neurosci . 2018 ; 41 : 323 – 48 .

Zhong J , Xing X , Gao Y , Pei L , Lu C , Sun H , et al . Distinct roles of TREM2 in central nervous system cancers and peripheral cancers . Cancer Cell . 2024 ; 42 ( 6 ): 968 – 84.e9 .

Smith TL , Yuan Z , Cardó‑Vila M , Sanchez Claros C , Adem A , Cui MH , et al . AAVP displaying octreotide for ligand‑directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas . Proc Natl Acad Sci U S A . 2016 ; 113 ( 9 ): 2466 – 71 .

Wang H , Zheng Q , Lu Z , Wang L , Ding L , Xia L , et al . Role of the nervous system in cancers: a review . Cell Death Discov . 2021 ; 7 ( 1 ): 76 .

Schmitd LB , Perez‑Pacheco C , D’Silva NJ . Nerve density in cancer: less is better . FASEB Bioadv . 2021 ; 3 ( 10 ): 773 – 86 .

Perez‑Pacheco C , Schmitd LB , Furgal A , Bellile EL , Liu M , Fattah A , et al . Increased nerve density adversely affects outcome in oral cancer . Clin Cancer Res . 2023 ; 29 ( 13 ): 2501 – 12 .

Schmitd LB , Perez‑Pacheco C , Bellile EL , Wu W , Casper K , Mierzwa M , et al . Spatial and transcriptomic analysis of perineural invasion in oral cancer . Clin Cancer Res . 2022 ; 28 ( 16 ): 3557 – 72 .

Heij LR , Tan X , Kather JN , Niehues JM , Sivakumar S , Heussen N , et al . Nerve fibers in the tumor microenvironment are co‑localized with lymphoid aggregates in pancreatic cancer . J Clin Med . 2021 ; 10 ( 3 ): 490 .

Tan X , Bednarsch J , Rosin M , Appinger S , Liu D , Wiltberger G , et al . PD‑1 + T‑cells correlate with nerve fiber density as a prognostic biomarker in patients with resected perihilar cholangiocarcinoma . Cancers (Basel) . 2022 . https://doi.org/10.3390/cancers14092190 .

Olar A , He D , Florentin D , Ding Y , Wheeler T , Ayala G . Biological cor‑relates of prostate cancer perineural invasion diameter . Hum Pathol . 2014 ; 45 ( 7 ): 1365 – 9 .

Olar A , He D , Florentin D , Ding Y , Ayala G . Biologic correlates and significance of axonogenesis in prostate cancer . Hum Pathol . 2014 ; 45 ( 7 ): 1358 – 64 .

Reeves FA , Battye S , Roth H , Peters JS , Hovens C , Costello AJ , et al . Pros‑tatic nerve subtypes independently predict biochemical recurrence in prostate cancer . J Clin Neurosci . 2019 ; 63 : 213 – 9 .

Iwasaki T , Hiraoka N , Ino Y , Nakajima K , Kishi Y , Nara S , et al . Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma . Cancer Sci . 2019 ; 110 ( 4 ): 1491 – 502 .

Dagogo‑Jack I , Shaw AT . Tumour heterogeneity and resistance to cancer therapies . Nat Rev Clin Oncol . 2018 ; 15 ( 2 ): 81 – 94 .

Zhu T , Wang T , Feng Z , Gao F , Zhang J , Jin C , et al . Glia maturation factor β as a novel independent prognostic biomarker and potential therapeutic target of kidney renal clear cell carcinoma . Front Oncol . 2022 ; 12 : 880100 .

Zhang L , Deng Y , Yang J , Deng W , Li L . Neurotransmitter receptor‑related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer . Front Cell Dev Biol . 2023 ; 11 : 1202193 .

Seyhan AA . Circulating liquid biopsy biomarkers in glioblastoma: advances and challenges . Int J Mol Sci . 2024 ; 25 ( 14 ): 7974 .

Santangelo A , Tamanini A , Cabrini G , Dechecchi MC . Circulating micro‑rnas as emerging non‑invasive biomarkers for gliomas . Ann Transl Med . 2017 ; 5 ( 13 ): 277 .

Lu WL , Kuang H , Gu J , Hu X , Chen B , Fan Y . Gap‑43 targeted indocyanine green‑loaded near‑infrared fluorescent probe for real‑time mapping of perineural invasion lesions in pancreatic cancer in vivo . Nanomedicine . 2023 ; 50 : 102671 .

Grey N , Silosky M , Lieu CH , Chin BB . Current status and future of targeted peptide receptor radionuclide positron emission tomogra‑phy imaging and therapy of gastroenteropancreatic‑neuroendocrine tumors . World J Gastroenterol . 2022 ; 28 ( 17 ): 1768 – 80 .

Fani M , Maecke HR , Okarvi SM . Radiolabeled peptides: valuable tools for the detection and treatment of cancer . Theranostics . 2012 ; 2 ( 5 ): 481 – 501 .

Virgolini I , Raderer M , Kurtaran A , Angelberger P , Banyai S , Yang Q , et al . Vasoactive intestinal peptide‑receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors . N Engl J Med . 1994 ; 331 ( 17 ): 1116 – 21 .

Reubi JC . Peptide receptors as molecular targets for cancer diagnosis and therapy . Endocr Rev . 2003 ; 24 ( 4 ): 389 – 427 .

Rangger C , Helbok A , Ocak M , Radolf T , Andreae F , Virgolini IJ , et al . Design and evaluation of novel radiolabelled vip derivatives for tumour targeting . Anticancer Res . 2013 ; 33 ( 4 ): 1537 – 46 .

You H , Shang W , Min X , Weinreb J , Li Q , Leapman M , et al . Sight and switch off: nerve density visualization for interventions targeting nerves in prostate cancer . Sci Adv . 2020 ; 6 ( 6 ): eaax6040 .

Gonzalez P , Debnath S , Chen YA , Hernandez E , Jha P , Dakanali M , et al . A theranostic small‑molecule prodrug conjugate for neuroendocrine prostate cancer . Pharmaceutics . 2023 ; 15 ( 2 ): 481 .

Shi HX , Tao HT , He JJ , Zhu FY , Xie CQ , Cheng YN , et al . Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemo‑therapy‑induced peripheral neuropathy in breast cancer . Mol Cancer . 2024 ; 23 ( 1 ): 152 .

Uccello TP , Lesch ML , Ullman NA , Kintzel SA , Gradzewicz LB , Velagaleti T , et al . Radiation therapy exacerbates tumor‑promoting innervation and nerve signaling in rectal cancer . Int J Radiat Oncol Biol Phys . 2023 ; 115 ( 3 ): 733 – 45 .

Tetzlaff SK , Reyhan E , Layer N , Bengtson CP , Heuer A , Schroers J , et al . Characterizing and targeting glioblastoma neuron‑tumor networks with retrograde tracing . Cell . 2024 ; 188 ( 2 ): 390 – 411.e36 .

Kwak S , Lee JY , Kim MJ , Lee HJ , Lee DK , Kang J , et al . Combination of PD‑1 checkpoint blockade and botulinum toxin type A1 improves antitumor responses in mouse tumor models of melanoma and colon carcinoma . Immunol Invest . 2023 ; 52 ( 6 ): 749 – 66 .

Zhang J , Liu J , Yue Y , Wang L , He Q , Xu S , et al . The immunotoxin target‑ing PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer . J Exp Clin Cancer Res . 2024 ; 43 ( 1 ): 173 .

Fang X , Ding H , Chen Y , Wang Q , Yuan X , Zhang C , et al . Wireless optogenetic targeting nociceptors helps host cells win the competi‑tive colonization in implant‑associated infections . Small Methods . 2024 ; 8 ( 12 ): e2400216 .

Watanabe M , Narita M , Hamada Y , Yamashita A , Tamura H , Ikegami D , et al . Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer . Mol Pain . 2018 ; 14 : 1744806918756406 .

Xu XR , Xiao Q , Hong YC , Liu YH , Liu Y , Tu J . Activation of dopaminergic VTA inputs to the mpfc ameliorates chronic stress‑induced breast tumor progression . CNS Neurosci Ther . 2021 ; 27 ( 2 ): 206 – 19 .

Zhang QR , Wang SX , Chen R . Integrated bioelectronic and optogenetic methods to study brain‑body circuits . ACS Nano . 2024 ; 18 ( 44 ): 30117 – 22 .

Deng Y , Xiao M , Wan AH , Li J , Sun L , Liang H , et al . RNA and RNA deriva‑tives: light and dark sides in cancer immunotherapy . Antioxid Redox Signal . 2022 ; 37 ( 16–18 ): 1266 – 90 .

Wang Y , Zhang L , Xu Z , Miao L , Huang L . MRNA vaccine with antigen‑specific checkpoint blockade induces an enhanced immune response against established melanoma . Mol Ther . 2018 ; 26 ( 2 ): 420 – 34 .

Sun Q , Hong Z , Zhang C , Wang L , Han Z , Ma D . Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends . Signal Transduct Target Ther . 2023 ; 8 ( 1 ): 320 .

Kon E , Ad‑El N , Hazan‑Halevy I , Stotsky‑Oterin L , Peer D . Targeting cancer with mRNA‑lipid nanoparticles: key considerations and future prospects . Nat Rev Clin Oncol . 2023 ; 20 ( 11 ): 739 – 54 .

Maryanovich M , Zahalka AH , Pierce H , Pinho S , Nakahara F , Asada N , et al . Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche . Nat Med . 2018 ; 24 ( 6 ): 782 – 91 .

Zhang Y , Liu X , Shen T , Wang Q , Zhou S , Yang S , et al . Small circu‑lar RNAs as vaccines for cancer immunotherapy . Nat Biomed Eng . 2025 ; 9 ( 2 ): 249 – 67 .

Lian X , Chatterjee S , Sun Y , Dilliard SA , Moore S , Xiao Y , et al . Bone‑marrow‑homing lipid nanoparticles for genome editing in dis‑eased and malignant haematopoietic stem cells . Nat Nanotechnol . 2024 ; 19 ( 9 ): 1409 – 17 .

Niu D , Wu Y , Lian J . Circular RNA vaccine in disease prevention and treatment . Signal Transduct Target Ther . 2023 ; 8 ( 1 ): 341 .

Zhu Y , Zhu L , Wang X , Jin H . RNA‑based therapeutics: an overview and prospectus . Cell Death Dis . 2022 ; 13 ( 7 ): 644 .

Zamecnik PC , Stephenson ML . Inhibition of rous sarcoma virus replica‑tion and cell transformation by a specific oligodeoxynucleotide . Proc Natl Acad Sci U S A . 1978 ; 75 ( 1 ): 280 – 4 .

Paunovska K , Loughrey D , Dahlman JE . Drug delivery systems for RNA therapeutics . Nat Rev Genet . 2022 ; 23 ( 5 ): 265 – 80 .

Zhang Q , Pan J , Xiong D , Wang Y , Miller MS , Sei S , et al . Pulmonary aero‑sol delivery of LET‑7B microrna confers a striking inhibitory effect on lung carcinogenesis through targeting the tumor immune microenvi‑ronment . Adv Sci . 2021 ; 8 ( 17 ): e2100629 .

El Fatimy R , Subramanian S , Uhlmann EJ , Krichevsky AM . Genome editing reveals glioblastoma addiction to microRNA‑10B . Mol Ther . 2017 ; 25 ( 2 ): 368 – 78 .

Zou Y , Sun X , Wang Y , Yan C , Liu Y , Li J , et al . Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment . Adv Mater . 2023 ; 35 ( 16 ): e2300777 .

Cohen ZR , Ramishetti S , Peshes‑Yaloz N , Goldsmith M , Wohl A , Zibly Z , et al . Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan‑grafted lipid‑based nanoparticles . ACS Nano . 2015 ; 9 ( 2 ): 1581 – 91 .

Wang Z , Tang XL , Zhao MJ , Zhang YD , Xiao Y , Liu YY , et al . Biomimetic hypoxia‑triggered RNAi nanomedicine for synergistically mediat‑ing chemo/radiotherapy of glioblastoma . J Nanobiotechnology . 2023 ; 21 ( 1 ): 210 .

Fan HY , Liang XH , Tang YL . Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk . MedComm . 2024 ; 5 ( 11 ): e784 .

Drost J , Clevers H . Organoids in cancer research . Nat Rev Cancer . 2018 ; 18 ( 7 ): 407 – 18 .

Lu T , Wang M , Zhou W , Ni Q , Yue Y , Wang W , et al . Decoding transcrip‑tional identity in developing human sensory neurons and organoid modeling . Cell . 2024 ; 187 ( 26 ): 7374 – 93.e28 .

Vaes N , Schonkeren SL , Rademakers G , Holland AM , Koch A , Gijbels MJ , et al . Loss of enteric neuronal NDRG4 promotes colorectal cancer via increased release of NID1 and FBLN2 . EMBO Rep . 2021 ; 22 ( 6 ): e51913 .

Kim J , Kim R , Lee W , Kim GH , Jeon S , Lee YJ , et al . Assembly of glioblas‑toma tumoroids and cerebral organoids: a 3d in vitro model for tumor cell invasion . Mol Oncol . 2024 . https://doi.org/10.1002/1878‑0261.13740 .

Ma X , Wang Q , Li G , Li H , Xu S , Pang D . Cancer organoids: a platform in basic and translational research . Genes Dis . 2024 ; 11 ( 2 ): 614 – 32 .

Marx V . Closing in on cancer heterogeneity with organoids . Nat Meth‑ods . 2024 ; 21 ( 4 ): 551 – 4 .

Wefel JS , Kayl AE , Meyers CA . Neuropsychological dysfunction associ‑ated with cancer and cancer therapies: a conceptual review of an emerging target . Br J Cancer . 2004 ; 90 ( 9 ): 1691 – 6 .

Staff NP , Grisold A , Grisold W , Windebank AJ . Chemotherapy‑induced peripheral neuropathy: a current review . Ann Neurol . 2017 ; 81 ( 6 ): 772 – 81 .

Bannwarth B , Kostine M . Nerve growth factor antagonists: is the future of monoclonal antibodies becoming clearer? . Drugs . 2017 ; 77 ( 13 ): 1377 – 87 .

Gibson EM , Nagaraja S , Ocampo A , Tam LT , Wood LS , Pallegar PN , et al . Methotrexate chemotherapy induces persistent tri‑glial dysregula‑tion that underlies chemotherapy‑related cognitive impairment . Cell . 2019 ; 176 ( 1–2 ): 43 – 55.e13 .

Pease‑Raissi SE , Pazyra‑Murphy MF , Li Y , Wachter F , Fukuda Y , Fen‑stermacher SJ , et al . Paclitaxel reduces axonal Bclw to initiate IP 3 R1‑dependent axon degeneration . Neuron . 2017 ; 96 ( 2 ): 373 – 86.e6 .

Sarfati D , Koczwara B , Jackson C . The impact of comorbidity on cancer and its treatment . CA . 2016 ; 66 ( 4 ): 337 – 50 .

Huang JW , Cao CA , Zheng WH , Jia CR , Liu X , Gao SQ , et al . The mecha‑nism of cancer‑depression comorbidity . Neuroscience . 2024 ; 556 : 25 – 30 .

Wang L , Zhang W , He X , Zha H , editors. Personalized prescription for comorbidity . In: Database Systems for Advanced Applications: 23rd International Conference, DASFAA 2018, Gold Coast, QLD, Australia, May 21–24, 2018, Proceedings, Part II 23 ; 2018 : Springer .

Stairmand J , Signal L , Sarfati D , Jackson C , Batten L , Holdaway M , et al . Consideration of comorbidity in treatment decision making in mul‑tidisciplinary cancer team meetings: a systematic review . Ann Oncol . 2015 ; 26 ( 7 ): 1325 – 32 .

Ojima K , Kakegawa W , Yamasaki T , Miura Y , Itoh M , Michibata Y , et al . Coordination chemogenetics for activation of GPCR‑type glutamate receptors in brain tissue . Nat Commun . 2022 ; 13 ( 1 ): 3167 .

Costa PAC , Silva WN , Prazeres P , Picoli CC , Guardia GDA , Costa AC , et al . Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression . Acta Neuropathol Commun . 2021 ; 9 ( 1 ): 183 .

Ben‑Shaanan TL , Azulay‑Debby H , Dubovik T , Starosvetsky E , Korin B , Schiller M , et al . Activation of the reward system boosts innate and adaptive immunity . Nat Med . 2016 ; 22 ( 8 ): 940 – 4 .

Gomez JL , Bonaventura J , Lesniak W , Mathews WB , Sysa‑Shah P , Rodriguez LA , et al . Chemogenetics revealed: dreadd occupancy and activation via converted clozapine . Science . 2017 ; 357 ( 6350 ): 503 – 7 .

Phillips JA , Hutchings C , Djamgoz MBA . Clinical potential of nerve input to tumors: a bioelectricity perspective . Bioelectricity . 2021 ; 3 ( 1 ): 14 – 26 .

Armbruster BN , Li X , Pausch MH , Herlitze S , Roth BL . Evolving the lock to fit the key to create a family of G protein‑coupled recep‑tors potently activated by an inert ligand . Proc Natl Acad Sci U S A . 2007 ; 104 ( 12 ): 5163 – 8 .

Oesterle TS , Bormann NL , Al‑Soleiti M , Kung S , Singh B , McGinnis MT , et al . Invasive and non‑invasive neuromodulation for the treatment of substance use disorders: a review of reviews . Brain Sci . 2025 ; 15 ( 7 ): 723 .

Soltani Dehnavi S , Eivazi Zadeh Z , Harvey AR , Voelcker NH , Parish CL , Williams RJ , et al . Changing fate: reprogramming cells via engineered nanoscale delivery materials . Adv Mater . 2022 ; 34 ( 33 ): e2108757 .

Couch Y , Buzàs EI , Di Vizio D , Gho YS , Harrison P , Hill AF , et al . A brief history of nearly everything ‑ the rise and rise of extracellular vesicles . J Extracell Vesicles . 2021 ; 10 ( 14 ): e12144 .

Luo W , Dai Y , Chen Z , Yue X , Andrade‑Powell KC , Chang J . Spatial and temporal tracking of cardiac exosomes in mouse using a nano‑lucif‑erase‑CD63 fusion protein . Commun Biol . 2020 ; 3 ( 1 ): 114 .

Beetler DJ , Di Florio DN , Bruno KA , Ikezu T , March KL , Cooper LT , et al . Extracellular vesicles as personalized medicine . Mol Aspects Med . 2023 ; 91 : 101155 .

Arsić A , Stajković N , Spiegel R , Nikić‑Spiegel I . Effect of vectashield‑induced fluorescence quenching on conventional and super‑resolution microscopy . Sci Rep . 2020 ; 10 ( 1 ): 6441 .

Zhu B , Yin H , Zhang D , Zhang M , Chao X , Scimeca L , et al . Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy . Cell Mol Immunol . 2024 ; 21 ( 5 ): 436 – 47 .

Benzaquen D , Lawrence YR , Taussky D , Zwahlen D , Oehler C , Champion A . The crosstalk between nerves and cancer‑a poorly understood phenomenon and new possibilities . Cancers (Basel) . 2024 ; 16 ( 10 ): 1875 .